Celcuity Inc. – NASDAQ:CELC
Founder-led company
Celcuity stock price today
$49.25
+35.41
+255.85%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Celcuity stock price monthly change
-22.12%
month
Celcuity stock price quarterly change
-22.12%
quarter
Celcuity stock price yearly change
-7.11%
year
Celcuity key metrics
Market Cap | 446.29M |
Enterprise value | 144.40M |
P/E | -3.8 |
EV/Sales | N/A |
EV/EBITDA | -3.79 |
Price/Sales | N/A |
Price/Book | 1.26 |
PEG ratio | 0.20 |
EPS | -2.78 |
Revenue | N/A |
EBITDA | -72.47M |
Income | -73.45M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCelcuity stock price history
Celcuity stock forecast
Celcuity financial statements
| Jun 2023 | 0 | -14.58M | |
|---|---|---|---|
| Sep 2023 | 0 | -18.40M | |
| Dec 2023 | 229.64K | -18.84M | -8207.55% |
| Mar 2024 | 0 | -21.61M |
| Sep 2025 | 0 | -22.73M | |
|---|---|---|---|
| Oct 2025 | 550K | -30.11M | -5475.71% |
| Dec 2025 | 0 | -14.15M | |
| Dec 2025 | 1.27M | -30.31M | -2377.89% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 153517191 | 43.38M | 28.26% |
|---|---|---|---|
| Sep 2023 | 142384181 | 49.48M | 34.76% |
| Dec 2023 | 191219398 | 51.45M | 26.91% |
| Mar 2024 | 188181054 | 54.44M | 28.93% |
| Jun 2023 | -9.66M | 8.08M | 171.54K |
|---|---|---|---|
| Sep 2023 | -12.74M | 6.25M | 15.24K |
| Dec 2023 | -18.53M | -41.21M | 64.65M |
| Mar 2024 | -17.06M | 3.53M | 14.08M |
Celcuity alternative data
| Aug 2023 | 45 |
|---|---|
| Sep 2023 | 45 |
| Oct 2023 | 45 |
| Nov 2023 | 45 |
| Dec 2023 | 45 |
| Jan 2024 | 45 |
| Feb 2024 | 45 |
| Mar 2024 | 45 |
| Apr 2024 | 45 |
| May 2024 | 55 |
| Jun 2024 | 55 |
| Jul 2024 | 55 |
Celcuity other data
3.69%
-80.02%
of CELC is owned by hedge funds
20
-19
493.26K
-10.70M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Dec 2023 | 0 | 25350 |
| Feb 2024 | 0 | 350 |
| Apr 2024 | 0 | 350 |
| Jun 2024 | 0 | 350 |
| Aug 2024 | 0 | 350 |
| Oct 2024 | 0 | 350 |
| Patent |
|---|
Grant Utility: Assays and methods for determining the responsiveness of an individual subject to a therapeutic agent Filling date: 10 Jun 2016 Issue date: 27 Jul 2021 |
Application Filling date: 5 Mar 2021 Issue date: 15 Jul 2021 |
Grant Utility: Whole cell assays and methods Filling date: 3 Jul 2018 Issue date: 13 Apr 2021 |
| Quarter | Transcript |
|---|---|
| Q1 2024 15 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 27 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 13 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 10 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of Celcuity stock today?
One share of Celcuity stock can currently be purchased for approximately $49.25.
-
When is Celcuity's next earnings date?
Unfortunately, Celcuity's (CELC) next earnings date is currently unknown.
-
Does Celcuity pay dividends?
No, Celcuity does not pay dividends.
-
How much money does Celcuity make?
Celcuity has a market capitalization of 446.29M.
-
What is Celcuity's stock symbol?
Celcuity Inc. is traded on the NASDAQ under the ticker symbol "CELC".
-
What is Celcuity's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Celcuity?
Shares of Celcuity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Celcuity's key executives?
Celcuity's management team includes the following people:
- Dr. Lance G. Laing Co-Founder, Chief Science Officer, Vice President, Sec. & Director(age: 63, pay: $333,900)
- Mr. Brian F. Sullivan Co-Founder, Chairman & Chief Executive Officer(age: 63, pay: $250,000)
- Ms. Vicky Hahne Chief Financial Officer(age: 59, pay: $177,650)
-
Is Celcuity founder-led company?
Yes, Celcuity is a company led by its founders Dr. Lance G. Laing and Mr. Brian F. Sullivan.
-
How many employees does Celcuity have?
As Jul 2024, Celcuity employs 55 workers, which is 22% more then previous quarter.
-
When Celcuity went public?
Celcuity Inc. is publicly traded company for more then 7 years since IPO on 20 Sep 2017.
-
What is Celcuity's official website?
The official website for Celcuity is celcuity.com.
-
Where are Celcuity's headquarters?
Celcuity is headquartered at 16305–36th Avenue North, Minneapolis, MN.
-
How can i contact Celcuity?
Celcuity's mailing address is 16305–36th Avenue North, Minneapolis, MN and company can be reached via phone at +7 633920767.
Celcuity company profile:
Celcuity Inc.
celcuity.comExchange:
NASDAQ
Full time employees:
55
Industry:
Biotechnology
Sector:
Healthcare
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
16305–36th Avenue North
Minneapolis, MN 55446
Minneapolis, MN 55446
CIK: 0001603454
ISIN: US15102K1007
CUSIP: 15102K100
